<DOC>
	<DOCNO>NCT00682565</DOCNO>
	<brief_summary>This study investigate whether symptom-limited exercise capacity ischemic cardiomyopathy patient angina deleteriously affect treatment CK-1827452 .</brief_summary>
	<brief_title>Pharmacokinetics ( PK ) Tolerability Intravenous ( IV ) Oral CK-1827452 Patients With Ischemic Cardiomyopathy Angina</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>1 . The patient sign Informed Consent Form/Patient Information Sheet study approve govern Institutional Review Board ( IRB ) Independent Ethics Committee ( IEC ) . 2 . The patient least 18 year old . 3 . The patient ischemic heart disease document one following : A history myocardial infarction document elevated CPKMB , troponin I T , presence electrocardiographic Q wave consistent myocardial infarction . Coronary angiography demonstrate least 1 major epicardial coronary artery ( i.e. , leave main , leave anterior descending , leave circumflex , right coronary artery ) stenosis least 60 % diameter great exclude stenosis leave main coronary artery unless revascularized coronary artery bypass grafting . 4 . The patient history ≥ 1 episode exercise induce angina within 2 month prior initial screen visit . 5 . The patient take beta blocker ACE inhibitor ( and/or ARB ) least 4 week . If prescribe , diuretic must administer least 4 week prior initial screen visit . 6 . The patient NYHA Class IIIII time enrollment ≥ 3 month prior initial screen visit . 7 . The patient history leave ventricular ejection fraction ( LVEF ) ≤ 35 % . 8 . The patient history EITHER leave ventricular enddiastolic diameter ≥ 55 mm , OR leave ventricular enddiastolic diameter index ≥ 32 mm/m2 . 9 . The patient expect complete least 4 minute Modified Naughton ETT ( see Appendix B ) . 10 . For female patient : The patient postmenopausal ( ≥ 1 year ) sterilize , childbearing potential , breastfeeding , pregnancy test negative , intention become pregnant course study , use contraceptive drug device . 1 . The patient acute myocarditis ; clinically significant restrictive , constrictive , hypertrophic obstructive cardiomyopathy ; clinically significant congenital heart disease . 2 . The patient SBP &gt; 160 mmHg , document least 3 separate occasion , least 10 minute apart . 3 . The patient DBP &gt; 90 mmHg , document least 3 separate occasion , least 10 minute apart . 4 . The patient level troponin I T , CPKMB &gt; upper limit normal time 6 week prior Initial Screening Visit ( Visit 1 ) randomization . 5 . The patient severe aortic mitral stenosis . 6 . The patient acute coronary syndrome , transient ischemic attack , revascularization procedure within 6 week Initial Screening Visit ( Visit 1 ) . 7 . The patient significant comorbid condition ( i.e. , lung disease , arthritis , peripheral vascular disease ) may limit treadmill exercise capacity . 8 . The patient renal impairment define calculated creatinine clearance &lt; 30 cc/min need renal replacement therapy . 9 . The patient know hepatic impairment define total bilirubin &gt; 3 mg/dL , ALT AST &gt; 2 time upper limit normal . 10 . The patient receive investigational drug device within 30 day 5 halflives , whichever great , randomization . 11 . The patient weighs &gt; 120 kg . 12 . The patient body temperature &gt; 38 ° C , confirm least 2 successive measurement , least 10 minute apart . 13 . The patient laboratory abnormality , opinion investigator , preclude participation study . 14 . The patient prior treatment CK1827452 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>